OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Applying Metastatic Renal Cell Carcinoma Guidelines Across Resource Settings: From Recommendations to Deliverable Care

Karen Canfell: The Need for Collaboration and Coordination in Space Flight and in Global Oncology

Uddiptya Goswami's Article About AI Role in Patient Navigation - CancerWorld

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Deborah McNamara Appointed National Director of Ireland’s National Cancer Control Programme

Oncology News, Insights, Stories by OncoDaily

100 Influential Women in Oncology
OncoDaily 100

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

LeukO 2026
Hematology

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 1

HMPL-A830
OncoIndustry

HUTCHMED and GSK Sign Up to $1.295B Licensing Deal for KRAS-EGFR Cancer Therapy HMPL-A830

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

Florian Lordick: The Evolving Role of Adjuvant Treatment in GIST

Radwa A. Yassin: Exciting and Historic Opportunity at The 1st ASCO Africa Regional Council

Christopher Jackson and the Question Oncology Cannot Avoid: Who Is Progress Really For?

Registration Open: ODC Life Sciences Invites Clinical Development Leaders to ‘Brazil Unlocked’ in Cambridge, Massachusetts

Manish Shah: Phase 2 NEST Trial Shows Promising Neoadjuvant BOT/BAL Results in Colon Cancer

FDA Approves Daraxonrasib: Here is What Oncologists Have to Say

Voices
Cancer Research UK Science and Innovation

Many Congratulations to all the Researchers Receiving Awards from Research Careers Committee - Cancer Research UK Science and Innovation

Lisa Butterfield on Cancer Vaccine Data Ahead of the SITC 2026 EU Immuno-Oncology Summit

Eter Natelauri: Georgia’s Experience in Developing Radiation Oncology Featured at ASTRO 2026

Ola Khorshid: Honored to be a Speaker at the 1st Tripoli Cancer Center Oncology Congress in Libya

Sylvester Comprehensive Cancer Center՛s Alex’s Place Supports Children with Cancer and Their Families

Wafaa M Rashed: What can Genetics, Environment, and Ancestry Tell us About why Childhood Leukemia Develops?

The Detroit Walk to End Colon Cancer has Raised More Than $61,000 - Colorectal Cancer Alliance

FDA Approvals
Ziihera

FDA Approves Ziihera With and Without Tislelizumab Plus Chemotherapy for First-Line HER2-Positive Gastroesophageal Adenocarcinoma

FDA Approves OncoSil Device for Distal Cholangiocarcinoma

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

OncoDaily 100
100 Influential Women in Oncology

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

Celebrities and Cancer

OncoCalendar

ESMO Advanced Course on Endocrine Sensitivity in HR+/HER2− Metastatic Breast Cancer 2026

European Society For Medical Oncology (ESMO)

25 Nov
Endocrine Sensitivity

CAR T-Cell Therapy in Pediatric and Young Adult B-ALL - Resonance

Acute Leukemia Research and Care Network (ALRCaN)

04 Sep
CAR T-Cell Therapy

2026 Advances in Chronic Graft-Versus-Host Disease

Memorial Sloan Kettering Cancer Center (MSK)

30 Oct
Graft-Versus-Host Disease

The ICISi Masterclass in Imaging of Prostate Cancer

International Cancer Imaging Society (ICIS)

23 Oct
ICISi Masterclass

The 37th Annual Fall Foliage Cancer Conference

Continuing Cancer Education, Inc

23 Oct
Fall Foliage Cancer

Immune-oncology
Dana-Farber Cancer Institute

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

What Happens If CAR T-Cell Therapy Fails? Relapse, Refractory Disease, and Next Treatment Options

Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

CAR T-Cell Therapy Death Rate: Treatment-Related Mortality, Causes of Death, and Risk Factors

CD20 × CD3 Bispecific Antibodies in B-Cell Lymphoma: Real-World Safety, Efficacy, and Healthcare Use in Spain

Gastrointestinal-Oncology
Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Esophageal Squamous Cell Carcinoma Biomarkers: PD-L1, Molecular Features and Emerging Targets

Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

Phase 2 NEST Trial: Neoadjuvant BOT/BAL in Localized Colon Cancer

FDA Approves Daraxonrasib: First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

SKYSCRAPER-07: Atezolizumab ± Tiragolumab After dCRT in Unresectable ESCC

TALENTOP: Liver Resection After Atezolizumab and Bevacizumab in Locally Advanced HCC

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
Bone-Only

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era

Enhertu Plus Pertuzumab Approved in the EU for First-Line HER2-Positive Metastatic Breast Cancer: A New Benchmark After More Than a Decade

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2− Advanced Breast Cancer: Why PANKU-Breast01 Matters

ctDNA During Neoadjuvant Therapy: Toward Real-Time Risk Stratification in Early Breast Cancer

5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer

ELEVATE: Can Elacestrant Become a New Endocrine Backbone After CDK4/6 Inhibition?

Lung-Oncology
Daraxonrasib

Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

SANOVO: Osimertinib Plus Savolitinib Moves MET-Directed Therapy Into First-Line EGFR-Mutated NSCLC

XPO1 Inhibition May Reprogram Immune Resistance in SCLC: The TRIM21–IRF3–TNFSF15–TREM2 Axis

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

Adjuvant Crizotinib Fails in Resected ALK-Positive NSCLC: What E4512 Tells Us About Targeted Therapy in Early Disease

7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC

When EGFR-Mutant NSCLC Becomes SCLC: Can Immunotherapy Become Relevant Again?

OncoDaily TV
Treatment Paradigms, Karine Tawagi

Evolving Treatment Paradigms in Muscle-Invasive Bladder Cancer

Cancer in Women

Cancer in Women As a Global Health and Economic Issue: Dr. Maira Caleffi

oncoffee, palliative

ONCOFFEE: Colorectal Cancer, Palliative Care, and the Human Side of Oncology: Santiago Fontes

Empowering Oncologists

Empowering Oncologists: How Policy impacts Medicine?

WHO

Mission is possible: WHO said 2030 – Rwanda said 2027: Dr. Sabin Nsanzimana

Current Landscape

The Current Landscape and Future of CAR-T in Aggressive B-Cell Lymphoma

Experts by Experience

Experts by Experience with Carmen Monge

Fighting Cervical Cancer

From Engineering to Fighting Cervical Cancer

Dr. Beatrice Addai Wiafe

Fighting Cancer With Peace And Love: Dr. Beatrice Addai Wiafe

Maggie Smith breast cancer

Dame Maggie Smith and Courageus Breast Cancer Journey: Filming Harry Potter During Chemotherapy

Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Not To Miss
LeukO 2026

Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 1

Etentamig Improves Response Rate and PFS in Phase 3 CERVINO Multiple Myeloma Trial

HUTCHMED and GSK Sign Up to $1.295B Licensing Deal for KRAS-EGFR Cancer Therapy HMPL-A830

Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer

AstraZeneca Completes Zegfrovy Deal for EGFR Exon 20 Insertion NSCLC

BeOne Medicines Reaches U.S. Government Agreement to Expand Access to Cancer Medicines

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

OncoGrants
Glioblastoma Therapeutics

NCI Glioblastoma Therapeutics Network U19 Grant 2026

CRI

CRI Irvington Postdoctoral Cancer Research Fellowship (March 2027 Cycle)

Pathway to Independence Award

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers 2026

Metastasis Research Network

NCI Metastasis Research Network U54 Grant 2026

NCI

NCI Academic–Industrial Partnerships for Cancer Imaging R01 Grant 2026

McCaskill-Stevens Career Development

NCI Worta McCaskill-Stevens Career Development Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Shikha Jain

Shikha Jain

Oncologists Location Chicago, USA
Wang Xishan

Wang Xishan

Oncologists Location Beijing, China
Imène Hadji

Imène Hadji

Oncologists Location Guelma, Algeria
Aparna Parikh

Aparna Parikh

Oncologists Location Boston, USA
Iyad Sultan

Iyad Sultan

Oncologists Location Amman, Jordan
Alice Bernard-Tessier

Alice Bernard-Tessier

Oncologists Location Villejuif, France
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia
Jyoti Malhotra

Jyoti Malhotra

Oncologists Location Duarte, USA

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Erika Hamilton

Erika Hamilton: Addressing Depression and Stress in Cancer Survivors

Mahmoud Gaballa

Mahmoud Gaballa: New Insights Into Bispecific Antibodies in Plasma Cell Leukemia

Dana-Farber Cancer Institute

Dana-Farber Study Links CDK2 Activity With Response to Immune Checkpoint Blockade

MASCC

Physical Activity in Cancer Care: Insights from the Latest Supportive Care Digest - MASCC

Allan Pereira

Allan Pereira: TALENTACE Strengthens TACE with Atezolizumab and Bevacizumab in HCC

Joshua Okyere

Joshua Okyere: Economic Dependence Is a Barrier to Cancer Screening

OncoDaily Medical Journal

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts

Radiation Oncology

10.69690/ODMJ-018-0826-7920

Short-Course Palliative Radiotherapy for Tumour-Related Bleeding in End-of-Life Care: A Focused Literature Review
Abstracts

Pediatric Oncology

10.69690/ODMJ-018-0826-7952

FLASH radiotherapy: A Potential Way to Protect the Developing Brain in Pediatric Oncology
Abstracts

GI Oncology

10.69690/ODMJ-018-0826-7947

Real World Clinical Insights in Combination of Trifluridine-Tipiracil with Bevacizumab for Metastatic Colorectal Cancer
Abstracts

Hematology

10.69690/ODMJ-018-0826-7945

Plasma cell survival: The impact of extracellular ATP
Abstracts

Breast Cancer

10.69690/ODMJ-018-0826-7965

A Systematic Comparison of ICG Fluorescence vs Dual-Tracer Sentinel Lymph Node Biopsy in Breast Cancer Staging
Abstracts